Academic Discovery

Academic Discovery is a specialized drug discovery consultancy and contract research organization (CRO) that provides strategic and technical expertise to the life sciences sector. Founded by Dr. Richard Weaver, the company focuses on optimizing the transition of therapeutic candidates from academic research into formal drug development. Its core services include expert guidance on ADME (Absorption, Distribution, Metabolism, and Excretion), pharmacokinetics (PK), and toxicology to improve the success rates of early-stage programs. By bridging the gap between basic science and industrial application, Academic Discovery assists biotechnology companies, academic institutions, and venture capital firms in de-risking their portfolios.